Skip to main content

Vaccine lotteries and personal appeals: The medically vulnerable find their priority status slipping away

Noted: Jonathan L. Temte, associate dean for public health and community engagement at the University of Wisconsin and a liaison to to the covid-19 work group that helped the CDC advisory panel issue its guidelines, called the result a “free-for-all.” The decisions could become even more torturous when a third vaccine made by Johnson & Johnson — which is expected to gain regulatory approval this weekend — joins the mix, though with only a trickle of supply at first.